Search research articles
Contact Us
Filters
Showing results (201-210 of 493) with videos related to
Page
of 50
Sort By:
RMD Open
|
July 28, 2023
Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review
Eric L Matteson, Marco Matucci-Cerinic, Michael Kreuter, et al.
Arthritis Research & Therapy
|
September 12, 2023
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
Anne Cauvet, Arthur Decellas, Christophe Guignabert, et al.
The Journal of Rheumatology
|
July 18, 2008
Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments
Natacha Thelier, Noémie Assous, Chantal Job-Deslandre, et al.
The Journal of Rheumatology
|
October 3, 2014
Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients
Judith Payet, Claire Goulvestre, Lisa Bialé, et al.
Journal of Scleroderma and Related Disorders
|
February 9, 2024
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis
Manon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.
The Journal of Investigative Dermatology
|
September 3, 2019
Estrogens Counteract the Profibrotic Effects of TGF-β and their Inhibition Exacerbates Experimental Dermal Fibrosis
Jérôme Avouac, Sonia Pezet, Virginie Gonzalez, et al.
Arthritis Research & Therapy
|
March 22, 2025
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
Oliver Distler, Madelon C Vonk, Arata Azuma, et al.
Arthritis Research & Therapy
|
May 30, 2019
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study
Janusz Jaworski, Marco Matucci-Cerinic, Hendrik Schulze-Koops, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)
|
April 13, 2021
Alice Combier, Sarah Wanono, Lucile Poiroux, et al.
Nature Communications
|
December 13, 2019
Trained immunity modulates inflammation-induced fibrosis
Mohamed Jeljeli, Luiza Gama Coelho Riccio, Ludivine Doridot, et al.
Page
of 50
Search research articles
Search
Showing results (201-210 of 493) with videos related to
Sort By:
Page
of 50
RMD Open
|
July 28, 2023
Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review
Eric L Matteson, Marco Matucci-Cerinic, Michael Kreuter, et al.
Arthritis Research & Therapy
|
September 12, 2023
Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis
Anne Cauvet, Arthur Decellas, Christophe Guignabert, et al.
The Journal of Rheumatology
|
July 18, 2008
Osteoarticular involvement in a series of 100 patients with sarcoidosis referred to rheumatology departments
Natacha Thelier, Noémie Assous, Chantal Job-Deslandre, et al.
The Journal of Rheumatology
|
October 3, 2014
Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients
Judith Payet, Claire Goulvestre, Lisa Bialé, et al.
Journal of Scleroderma and Related Disorders
|
February 9, 2024
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosis
Manon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.
The Journal of Investigative Dermatology
|
September 3, 2019
Estrogens Counteract the Profibrotic Effects of TGF-β and their Inhibition Exacerbates Experimental Dermal Fibrosis
Jérôme Avouac, Sonia Pezet, Virginie Gonzalez, et al.
Arthritis Research & Therapy
|
March 22, 2025
Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
Oliver Distler, Madelon C Vonk, Arata Azuma, et al.
Arthritis Research & Therapy
|
May 30, 2019
Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study
Janusz Jaworski, Marco Matucci-Cerinic, Hendrik Schulze-Koops, et al.
Revue Du Rhumatisme (Ed. Francaise : 1993)
|
April 13, 2021
Alice Combier, Sarah Wanono, Lucile Poiroux, et al.
Nature Communications
|
December 13, 2019
Trained immunity modulates inflammation-induced fibrosis
Mohamed Jeljeli, Luiza Gama Coelho Riccio, Ludivine Doridot, et al.
Page
of 50